CC BY-NC-ND 4.0 · The Arab Journal of Interventional Radiology 2020; 4(01): 44-46
DOI: 10.4103/AJIR.AJIR_29_19
Case Report

Intracardiac Migration Following Percutaneous Computed Tomography-Guided Fiducial Marker Implantation for Pulmonary Metastasis: A Rare Complication

Duaa Alhindi
King Abdulaziz Medical City, Ministry of National Guard, Riyadh, Saudi Arabia
,
Yousof AbdulRahman Al Zahrani
Department of Medical Imaging, Division of Vascular and Interventional Radiology, King Abdulaziz Medical City, Ministry of National Guard – Health Affairs, Riyadh, Saudi Arabia
,
Azzam Khankan
Department of Medical Imaging, Division of Vascular and Interventional Radiology, King Abdulaziz Medical City, Ministry of National Guard – Health Affairs, Riyadh, Saudi Arabia
› Author Affiliations
Financial support and sponsorship Nil.

A 41-year-old female with rectal cancer and lung metastasis underwent percutaneous transthoracic placement of fiducial marker. Postprocedure scan showed the migration of one of the fiducial markers to the left ventricle. Intracardiac fiducial marker migration is a rare complication but can happen, especially with centrally located lesions. Physicians and patients should be aware of this risk.



Publication History

Received: 29 October 2019
Received: 04 November 2019

Accepted: 14 November 2019

Article published online:
16 March 2021

© 2019. The Arab Journal of Interventional Radiology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Lax I, Blomgren H, Näslund I, Svanström R. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 1994;33:677-83.
  • 2 Pawa S, Ehrinpreis M, Mutchnick M, Janisse J, Dhar R, Siddiqui FA. Percutaneous liver biopsy is safe in chronic hepatitis C patients with end-stage renal disease. Clin Gastroenterol Hepatol 2007;5:1316-20.
  • 3 Bhagat N, Fidelman N, Durack JC, Collins J, Gordon RL, LaBerge JM, et al. Complications associated with the percutaneous insertion of fiducial markers in the thorax. Cardiovasc Intervent Radiol 2010;33:1186-91.
  • 4 Kothary N, Heit JJ, Louie JD, Kuo WT, Loo BW Jr, Koong A, et al. Safety and efficacy of percutaneous fiducial marker implantation for image-guided radiation therapy. J Vasc Interv Radiol 2009;20:235-9.
  • 5 Yousefi S, Collins BT, Reichner CA, Anderson ED, Jamis-Dow C, Gagnon G, et al. Complications of thoracic computed tomography-guided fiducial placement for the purpose of stereotactic body radiation therapy. Clin Lung Cancer 2007;8:252-6.
  • 6 Kothary N, Heit JJ, Louie JD, Kuo WT, Loo BW Jr, Koong A, et al. Safety and efficacy of percutaneous fiducial marker implantation for image-guided radiation therapy. J Vasc Interv Radiol 2009;20:235-9.
  • 7 Cousin F, Gérard L, Joskin J. Left Cardiac Migration of a Lung Fiducial Marker. J Vasc Interv Radiol 2019;30:445.
  • 8 Hennessey H, Valenti D, Cabrera T, Panet-Raymond V, Roberge D. Cardiac embolization of an implanted fiducial marker for hepatic stereotactic body radiotherapy: A case report. J Med Case Rep 2009;3:140.
  • 9 Farkas EA, Stoeckel DA, Nassif AS, Lim MJ, Naunheim KS. Intracoronary fiducial embolization after percutaneous placement for stereotactic radiosurgery. Ann Thorac Surg 2012;93:1715-7.